Free Trial

Medicenna Therapeutics (MDNAF) Earnings Date, Estimates & Call Transcripts

$0.31 -0.01 (-2.41%)
As of 05/29/2026 03:53 PM Eastern

Medicenna Therapeutics Earnings Summary

Medicenna Therapeutics released Q3 2026 earnings on February 12, 2026, reporting an EPS of -$0.05, which missed the consensus estimate of -$0.04 by $0.01. With a trailing EPS of -$0.11, Medicenna Therapeutics' earnings are expected to decrease next year, from ($0.18) to ($0.20) per share.

Q3 2026 Earnings Resources

Consensus EPS
(Feb. 12)
-$0.04
Actual EPS
(Feb. 12)
-$0.05 Missed By -$0.01
Get Medicenna Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Medicenna Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Medicenna Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q4 20261-$0.05-$0.05-$0.05
2026 1 -$0.05 -$0.05 -$0.05
Q1 20271-$0.05-$0.05-$0.05
Q2 20271-$0.05-$0.05-$0.05
Q3 20271-$0.06-$0.06-$0.06
Q4 20271-$0.06-$0.06-$0.06

Medicenna Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
2/12/2026Q3 2026-$0.04-$0.05 -$0.01-$0.06--

Data powered by Fiscal.ai.

Medicenna Therapeutics Earnings - Frequently Asked Questions

Medicenna Therapeutics (OTCMKTS:MDNAF) last announced its quarterly earning data on Thursday, February 12, 2026. Learn more on MDNAF's earnings history.

In the previous quarter, Medicenna Therapeutics (OTCMKTS:MDNAF) missed the analysts' consensus estimate of ($0.04) by $0.01 with a reported earnings per share (EPS) of ($0.05). Learn more on analysts' earnings estimate vs. MDNAF's actual earnings.

Medicenna Therapeutics (OTCMKTS:MDNAF) has a recorded net income of -$8.48 million. MDNAF has generated -$0.11 earnings per share over the last four quarters.

Medicenna Therapeutics' earnings are expected to decrease from ($0.18) per share to ($0.20) per share in the next year.


This page (OTCMKTS:MDNAF) was last updated on 5/31/2026 by MarketBeat.com Staff.
From Our Partners